Spots Global Cancer Trial Database for stage iii gastric cancer
Every month we try and update this database with for stage iii gastric cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | NCT00004236 | Esophageal Canc... Gastric Cancer | pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | NCT00002722 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | NCT00006389 | Stage III Gastr... Stage IV Gastri... | bryostatin 1 cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | NCT00524186 | Esophageal Canc... Gastric Cancer | fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... flow cytometry pharmacological... | - 120 Years | Roswell Park Cancer Institute | |
S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer | NCT00134095 | Gastric Cancer | irinotecan hydr... tegafur-gimerac... adjuvant therap... conventional su... neoadjuvant the... | 20 Years - 75 Years | National Cancer Institute (NCI) | |
S0425 Oxaliplatin, Capecitabine, and RT in Treating Patients W/Stomach Cancer That Can Be Removed By Surgery | NCT00335959 | Gastric Cancer | capecitabine oxaliplatin conventional su... radiation thera... | 18 Years - | SWOG Cancer Research Network | |
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | NCT00004873 | Gastric Cancer | cisplatin docetaxel epirubicin hydr... fluorouracil | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery | NCT00011960 | Esophageal Canc... Gastric Cancer | cisplatin paclitaxel adjuvant therap... radiation thera... | - | Radiation Therapy Oncology Group | |
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | NCT00002722 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | NCT00025532 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | iodine I 131 mo... | 19 Years - | University of California, San Francisco | |
DX-8951f in Treating Patients With Metastatic Stomach Cancer | NCT00017212 | Esophageal Canc... Gastric Cancer | exatecan mesyla... | 18 Years - | Daiichi Sankyo | |
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | NCT00003125 | Breast Cancer Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc... Unspecified Adu... | ALVAC-CEA vacci... aldesleukin sargramostim vaccinia-CEA va... | 18 Years - | Georgetown University | |
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
Massage Therapy in Treating the Symptoms of Patients With Locally Advanced or Metastatic Cancer | NCT00253708 | Cancer | management of t... massage therapy pain therapy psychosocial as... quality-of-life... | 18 Years - 120 Years | Beth Israel Deaconess Medical Center | |
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00089362 | Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas... | alvespimycin hy... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | NCT00003862 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... paclitaxel conventional su... neoadjuvant the... radiation thera... | 0 Years - 120 Years | Radiation Therapy Oncology Group | |
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer | NCT00985192 | Esophageal Canc... Gastric Cancer | everolimus laboratory biom... | 18 Years - | Translational Oncology Research International | |
Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus | NCT00003192 | Esophageal Canc... Gastric Cancer | aminocamptothec... | 18 Years - | University of Chicago | |
Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | NCT00006038 | Esophageal Canc... Gastric Cancer | cisplatin docetaxel floxuridine fluorouracil leucovorin calc... conventional su... | - | Memorial Sloan Kettering Cancer Center | |
S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer | NCT00103324 | Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage III Gastr... Stage IV Gastri... | lapatinib ditos... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | NCT00489515 | Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | 18 Years - 120 Years | Wake Forest University Health Sciences | ||
Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | NCT00027534 | Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ... | TRICOM-CEA(6D) | 18 Years - | Duke University | |
Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | NCT00087191 | Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga... | EF5 motexafin lutet... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | NCT00006081 | Esophageal Canc... Gastric Cancer | Bryostatin-1 Paclitaxel (Tax... | 18 Years - | M.D. Anderson Cancer Center | |
Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer | NCT00004236 | Esophageal Canc... Gastric Cancer | pegylated lipos... | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | NCT00019474 | Extrahepatic Bi... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | filgrastim recombinant int... fluorouracil hydroxyurea | 18 Years - 120 Years | Montefiore Medical Center | |
Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer | NCT00003298 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... paclitaxel surgery radiation thera... | 18 Years - | Eastern Cooperative Oncology Group | |
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | NCT00016380 | Cancer | dexamethasone ondansetron quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach | NCT00601705 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil oxaliplatin adjuvant therap... neoadjuvant the... | 18 Years - | Case Comprehensive Cancer Center | |
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT01172028 | Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer | Taxotere (Docet... Alimta (Pemetre... | 18 Years - | University of Arizona | |
Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | NCT00004873 | Gastric Cancer | cisplatin docetaxel epirubicin hydr... fluorouracil | 18 Years - 70 Years | Swiss Group for Clinical Cancer Research | |
Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer | NCT00601510 | Gastric Cancer | capecitabine cisplatin imatinib mesyla... | 18 Years - | Technical University of Munich | |
Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | NCT00005060 | Gastric Cancer | Taxotere-Cispla... Immediate surge... | 18 Years - 75 Years | Swiss Group for Clinical Cancer Research | |
Irinotecan in Treating Patients With Esophageal or Stomach Cancer | NCT00003748 | Esophageal Canc... Gastric Cancer | irinotecan hydr... | 18 Years - | Jonsson Comprehensive Cancer Center | |
Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer | NCT00006389 | Stage III Gastr... Stage IV Gastri... | bryostatin 1 cisplatin laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Bortezomib in Treating Patients With Unresectable or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | NCT00074009 | Gastric Cancer | bortezomib | 18 Years - | National Cancer Institute (NCI) | |
Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00022139 | Esophageal Canc... Gastric Cancer | carboplatin fluorouracil paclitaxel conventional su... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | NCT00005049 | Colorectal Canc... Gastric Cancer Gastrointestina... Gastrointestina... Ovarian Cancer Peritoneal Cavi... Small Intestine... | carboplatin cisplatin floxuridine | 18 Years - | NYU Langone Health | |
Saracatinib in Treating Patients With Locally Advanced or Metastatic Stomach or Gastroesophageal Junction Cancer | NCT00607594 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Gastr... Stage III Gastr... Stage III Esoph... Stage IV Esopha... Stage IV Gastri... | saracatinib | 18 Years - | National Cancer Institute (NCI) | |
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | NCT00052910 | Esophageal Canc... Gastric Cancer | cisplatin epirubicin hydr... fluorouracil leucovorin calc... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer | NCT00524186 | Esophageal Canc... Gastric Cancer | fluorouracil irinotecan hydr... leucovorin calc... sunitinib malat... flow cytometry pharmacological... | - 120 Years | Roswell Park Cancer Institute | |
Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer | NCT00006038 | Esophageal Canc... Gastric Cancer | cisplatin docetaxel floxuridine fluorouracil leucovorin calc... conventional su... | - | Memorial Sloan Kettering Cancer Center | |
S-1 and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage III Stomach Cancer | NCT00182611 | Gastric Cancer | cisplatin tegafur-gimerac... adjuvant therap... conventional su... neoadjuvant the... | 20 Years - | National Cancer Institute (NCI) | |
Bryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach Cancer | NCT00005599 | Esophageal Canc... Gastric Cancer | bryostatin 1 paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer | NCT00103324 | Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage III Gastr... Stage IV Gastri... | lapatinib ditos... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | NCT00006081 | Esophageal Canc... Gastric Cancer | Bryostatin-1 Paclitaxel (Tax... | 18 Years - | M.D. Anderson Cancer Center | |
Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer | NCT00006081 | Esophageal Canc... Gastric Cancer | Bryostatin-1 Paclitaxel (Tax... | 18 Years - | M.D. Anderson Cancer Center | |
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | NCT00003125 | Breast Cancer Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc... Unspecified Adu... | ALVAC-CEA vacci... aldesleukin sargramostim vaccinia-CEA va... | 18 Years - | Georgetown University | |
Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT01172028 | Breast Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Lung Cancer Ovarian Cancer Prostate Cancer | Taxotere (Docet... Alimta (Pemetre... | 18 Years - | University of Arizona | |
Combination Chemotherapy Plus Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Esophagus or Stomach | NCT00009880 | Esophageal Canc... Gastric Cancer | filgrastim cisplatin fluorouracil paclitaxel radiation thera... | - | Radiation Therapy Oncology Group | |
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | NCT00089362 | Male Breast Can... Recurrent Adeno... Recurrent Basal... Recurrent Breas... Recurrent Colon... Recurrent Esthe... Recurrent Gastr... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Melan... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Ovari... Recurrent Prost... Recurrent Renal... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage III Adeno... Stage III Basal... Stage III Colon... Stage III Esthe... Stage III Gastr... Stage III Inver... Stage III Lymph... Stage III Lymph... Stage III Melan... Stage III Midli... Stage III Mucoe... Stage III Ovari... Stage III Renal... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IIIB Brea... Stage IIIC Brea... Stage IV Adenoi... Stage IV Basal ... Stage IV Breast... Stage IV Colon ... Stage IV Esthes... Stage IV Gastri... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Melano... Stage IV Midlin... Stage IV Mucoep... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Unspecified Adu... Untreated Metas... | alvespimycin hy... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach | NCT00003237 | Esophageal Canc... Gastric Cancer | cisplatin paclitaxel surgical proced... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
Gene Therapy in Treating Patients With Cancer | NCT00004178 | Cancer | therapeutic aut... | 18 Years - | Roger Williams Medical Center | |
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer | NCT00537121 | Esophageal Canc... Gastric Cancer Liver Cancer | fluorouracil irinotecan hydr... leucovorin calc... vorinostat pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | NCT00003862 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... paclitaxel conventional su... neoadjuvant the... radiation thera... | 0 Years - 120 Years | Radiation Therapy Oncology Group | |
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | NCT00004065 | Bladder Cancer Breast Cancer Colorectal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Lung Cancer Melanoma (Skin) Ovarian Cancer Prostate Cancer Unspecified Adu... | tanespimycin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients | NCT00253383 | Cancer | counseling inte... educational int... psychosocial as... quality-of-life... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | NCT00016380 | Cancer | dexamethasone ondansetron quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | NCT00002615 | Gastric Cancer | cisplatin epirubicin hydr... fluorouracil conventional su... | - | National Cancer Institute (NCI) | |
Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer | NCT00033657 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... paclitaxel conventional su... radiation thera... | 18 Years - | Eastern Cooperative Oncology Group | |
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | NCT00005638 | Esophageal Canc... Gastric Cancer | cisplatin irinotecan hydr... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer | NCT00002783 | Gastric Cancer | cisplatin floxuridine fluorouracil leucovorin calc... conventional su... | - | Memorial Sloan Kettering Cancer Center | |
Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | NCT00004099 | Gastric Cancer | cisplatin fluorouracil leucovorin calc... neoadjuvant the... | 18 Years - 69 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction | NCT00004911 | Colorectal Canc... Constipation, I... Gastric Cancer Gastrointestina... Gastrointestina... Quality of Life Small Intestine... | bowel obstructi... quality-of-life... | 18 Years - | Northwestern University | |
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction | NCT00004910 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Gastrointestina... Pancreatic Canc... Quality of Life Small Intestine... | bowel obstructi... quality-of-life... | 18 Years - | Northwestern University | |
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | NCT00005049 | Colorectal Canc... Gastric Cancer Gastrointestina... Gastrointestina... Ovarian Cancer Peritoneal Cavi... Small Intestine... | carboplatin cisplatin floxuridine | 18 Years - | NYU Langone Health |